Related content

Treatment of a patient with a nodal peripheral T-cell lymphoma (Angioimmunoblastic T-cell lymphoma) with a human monoclonal antibody against the CD4 antigen (HuMax-CD4)

By Hagberg H.   Pettersson M.   Bjerner T.   Enblad G.  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 191-194

Humana Press, Inc

Access to resources Recommend Favorite

CD4⁺CD25⁺FoxP3⁺ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas

By El Andaloussi Abdeljabar   Lesniak Maciej  

Journal of Neuro-Oncology, Vol. 83, Iss. 2, 2007-06 ,pp. : 145-152

Springer Publishing Company

Access to resources Recommend Favorite

Depletion of CD4⁺CD25⁺ Regulatory T Cells Promotes a Tumor-Specific Immune Response in Pancreas Cancer–Bearing Mice

By Viehl Carsten   Moore Todd   Liyanage Udaya   Frey Daniel   Ehlers Jesmin   Eberlein Timothy   Goedegebuure Peter   Linehan David  

Annals of Surgical Oncology, Vol. 13, Iss. 9, 2006-09 ,pp. : 1252-1258

Springer Publishing Company

Access to resources Recommend Favorite

Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen

By Ali Sumia   Mulryan Kate   Taher Taher   Stern Peter  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 165-180

Springer Publishing Company

Access to resources Recommend Favorite

CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer

By Kmieciak Maciej  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 385-394

Springer Publishing Company

Access to resources Recommend Favorite